Amber Watson

Bachelor of Medicine and Bachelor of Science,  CharitĂ© - Universitätsmedizin Berlin 

Location: India

Consulting Services

Journal Manuscript Research Consulting Career Advice and Mentoring Admin and Customer Support Pharma-CRO-Device

Areas Of Interest

Low-Grade Squamous Intraepithelial Lesions Rilpivirine Hydrochloride Fragile X Syndrome Benzoate 4-Monooxygenase Plants, French Bean Kinase, DAP Deglycase, Parkinsonism Associated Antigens, CDw217 Aqueduct of Vestibule Tests, Radioallergosorbent Ecology, Social Codon Preference P2X7 Receptors, Purinergic Long-Beaked Common Dolphins Dihydronicotinamide Adenine Dinucleotide Bonobos Aubergines Sphenoidal Fontanel Marble Bones, Autosomal Dominant P Hydroxyphenylpyruvate Oxidase Postpoliomyelitis Syndrome alpha Hemocyanins BBK8 Forensic Science Trichorhinophalangeal Syndrome Type 2 Variegate Porphyria HTLV-Associated Leukemia-Lymphoma Syncopes, Cerebral Acid Aspiration Syndromes Glycosyl Phosphatidylinositol Locus Ceruleus Complex Nuclear Receptor Subfamily 4, Group A, Member 1 Catheterization, Peripheral Venous Polyglactin 910 Acinous Cells

Professional Narrative

Dr. Amber Watson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Watson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Executive Director, Mayo Clinic 1987
Executive Director, Harvard Med 1990

Education

Doctor of osteopathic medicine, Weill Medical College 2008
Doctor of osteopathic medicine, Harvard Medical School 1991

Referees


Publications

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :